Institutional Ownership
Passage Bio Inc
CUSIP 702712209COM NEWPASGQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
32
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Lynx1 Capital Management LP | 623.7K | $4.90M |
| 2 | Vestal Point Capital, LP | 305.0K | $2.39M |
| 3 | Renaissance Technologies LLC | 133.6K | $1.05M |
| 4 | Eversept Partners, LP | 131.6K | $1.03M |
| 5 | Yiheng Capital Management, L.P. | 86.1K | $675.9K |
| 6 | Ikarian Capital, LLC | 68.1K | $534.8K |
| 7 | Erste Asset Management Gmbh | 85.3K | $526.9K |
| 8 | Geode Capital Management, LLC | 41.4K | $324.9K |
| 9 | Blackrock, Inc. | 28.6K | $224.5K |
| 10 | Ubs Group AG | 27.5K | $215.9K |